{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:02:38Z","timestamp":1790827358524,"version":"4.1.0"},"reference-count":160,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011962","name":"Research Center for Infectious Diseases and Tropical Medicine, Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["72881"],"award-info":[{"award-number":["72881"]}],"id":[{"id":"10.13039\/100011962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-026-01574-3","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:47:51Z","timestamp":1787636871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The gut microbiota\u2013miRNA axis in multiple sclerosis: Mechanisms and therapeutic potentials"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-4415","authenticated-orcid":false,"given":"Farzaneh","family":"Rafie Sedaghat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6648-0893","authenticated-orcid":false,"given":"Alka","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-0953","authenticated-orcid":false,"given":"Vahdat","family":"Poortahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5577-1115","authenticated-orcid":false,"given":"Samaneh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-8795","authenticated-orcid":false,"given":"Hossein Samadi","family":"Kafil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5858-8079","authenticated-orcid":false,"given":"Mehdi Meskini","family":"Heydarlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7330-3649","authenticated-orcid":false,"given":"Somayeh","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-2040","authenticated-orcid":false,"given":"Elham","family":"Mehdizadehfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4939-9895","authenticated-orcid":false,"given":"Yalda","family":"Sadeghpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3482-2403","authenticated-orcid":false,"given":"Roqaiyeh","family":"Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0803-954X","authenticated-orcid":false,"given":"Tohid Samadpour","family":"Zahmat-dar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.55133\/eji.310407","volume":"31","author":"BM Abaas","year":"2024","unstructured":"Abaas BM, Darweesh MF (2024) Profiles of miRNA expression and IFN-\u03b3 serum level as biomarker for the development of Multiple Sclerosis. Egypt J Immunol 31:62\u201370. https:\/\/doi.org\/10.55133\/eji.310407","journal-title":"Egypt J Immunol"},{"key":"1574_CR2","doi-asserted-by":"publisher","first-page":"9048920","DOI":"10.1155\/2017\/9048920","volume":"2017","author":"M Adamczyk-Sowa","year":"2017","unstructured":"Adamczyk-Sowa M, Medrek A, Madej P, Michlicka W, Dobrakowski P (2017) Does the gut microbiota influence immunity and inflammation in multiple sclerosis pathophysiology? J Immunol Res 2017:9048920. https:\/\/doi.org\/10.1155\/2017\/9048920","journal-title":"J Immunol Res"},{"key":"1574_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s10482-026-02304-y","volume":"119","author":"S Ahmadi","year":"2026","unstructured":"Ahmadi S, Sedaghat FR, Asl YM, Khabbaz A, Hosseinzadeh N, Poortahmasbe V, Hasani R, Hosseini S, Yazdchi M, Mehdizadehfar E, Salehi-Pourmehr H, Naseri A, Hasani A (2026) Faecalibacterium prausnitzii and Akkermansia muciniphila: driving the multiple sclerosis \u2013 a systematic review. Antonie Van Leeuwenhoek 119:100 [Note: verify DOI\/publication year]","journal-title":"Antonie Van Leeuwenhoek"},{"key":"1574_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/20552173221086662","volume":"8","author":"KF Al","year":"2022","unstructured":"Al KF, Craven LJ, Gibbons S, Parvathy SN, Wing AC, Graf C, Parham KA, Kerfoot SM, Wilcox H, Burton JP (2022) Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: a pilot randomized controlled trial. Mult Scler J Exp Transl Clin 8:20552173221086662. https:\/\/doi.org\/10.1177\/20552173221086662","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"1574_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2024.104903","volume":"137","author":"R Al-Temaimi","year":"2024","unstructured":"Al-Temaimi R, Alshammari N, Alroughani R (2024) Analysis of potential microRNA biomarkers for multiple sclerosis. Exp Mol Pathol 137:104903. https:\/\/doi.org\/10.1016\/j.yexmp.2024.104903","journal-title":"Exp Mol Pathol"},{"key":"1574_CR6","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1007\/s00394-020-02441-8","volume":"60","author":"F Algieri","year":"2021","unstructured":"Algieri F, Garrido-Mesa J, Vezza T, Rodr\u00edguez-Sojo MJ, Rodr\u00edguez-Cabezas ME, Olivares M, Garc\u00eda F, G\u00e1lvez J, Mor\u00f3n R, Rodr\u00edguez-Nogales A (2021) Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs. Eur J Nutr 60:2537\u20132551. https:\/\/doi.org\/10.1007\/s00394-020-02441-8","journal-title":"Eur J Nutr"},{"key":"1574_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105764","volume":"89","author":"S Alipour","year":"2024","unstructured":"Alipour S, Amanallahi P, Baradaran B, Aghebati-Maleki A, Soltani-Zangbar MS, Aghebati-Maleki L (2024) Altered gene expression of miR-155 in peripheral blood mononuclear cells of multiple sclerosis patients: correlation with TH17 frequency, inflammatory cytokine profile and autoimmunity. Mult Scler Relat Disord 89:105764. https:\/\/doi.org\/10.1016\/j.msard.2024.105764","journal-title":"Mult Scler Relat Disord"},{"key":"1574_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2024.138036","volume":"844","author":"S Alipour","year":"2025","unstructured":"Alipour S, Aghebati-Maleki A, Reza Sadeghi M, Soltani-Zangbar MS, Khakpour A, Aghebati-Maleki L (2025) Altered miR-10a gene expression in peripheral blood mononuclear cells correlates with frequency of T regulatory cells and cytokine profile in multiple sclerosis patients. Neurosci Lett 844:138036. https:\/\/doi.org\/10.1016\/j.neulet.2024.138036","journal-title":"Neurosci Lett"},{"key":"1574_CR9","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1212\/WNL.0000000000209393","volume":"104","author":"O Anani","year":"2025","unstructured":"Anani O, Al Shimi R, Alkabi A, Abu-Salih AQ, Al Bdour M (2025) The Impact of Gut Microbiota Modulation on Disease Progression and Symptom Management in Multiple Sclerosis (P12-1.004). Neurology 104:5393. https:\/\/doi.org\/10.1212\/WNL.0000000000209393","journal-title":"Neurology"},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaut.2012.12.007","volume":"41","author":"Y Ando","year":"2013","unstructured":"Ando Y, Yang GX, Kenny TP, Kawata K, Zhang W, Huang W, Leung PS, Lian ZX, Okazaki K, Ansari AA (2013) Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-\u03b2 receptor type II mouse. J Autoimmun 41:111\u2013119. https:\/\/doi.org\/10.1016\/j.jaut.2012.12.007","journal-title":"J Autoimmun"},{"key":"1574_CR11","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s12035-012-8272-9","volume":"45","author":"C Angerstein","year":"2012","unstructured":"Angerstein C, Hecker M, Paap BK, Koczan D, Thamilarsan M, Thiesen HJ, Zettl UK (2012) Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis. Mol Neurobiol 45:520\u2013535. https:\/\/doi.org\/10.1007\/s12035-012-8272-9","journal-title":"Mol Neurobiol"},{"key":"1574_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:451\u2013455. https:\/\/doi.org\/10.1038\/nature12726","journal-title":"Nature"},{"key":"1574_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1136\/gut.2005.085373","volume":"55","author":"MC Arrieta","year":"2006","unstructured":"Arrieta MC, Bistritz L, Meddings JB (2006) Alterations in intestinal permeability. Gut 55:1512\u20131520. https:\/\/doi.org\/10.1136\/gut.2005.085373","journal-title":"Gut"},{"key":"1574_CR14","doi-asserted-by":"publisher","unstructured":"Azam HMH, Mumtaz M, R\u00f6diger S, Schierack P, Hussain N, Aisha A (2025) MicroRNAs in neurodegenerative diseases: from molecular mechanisms to clinical biomarkers, detection methods and therapeutic strategies\u2014advances and challenges. Neurol Sci 1\u201343. https:\/\/doi.org\/10.1007\/s10072-025-08123-5","DOI":"10.1007\/s10072-025-08123-5"},{"key":"1574_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells14131018","volume":"14","author":"C Barbetta","year":"2025","unstructured":"Barbetta C, Bonomi F, Lepri G, Furst DE, Randone SB, Guiducci S (2025) Mesenchymal stem-cell-derived exosomes and microRNAs: advancing cell-free therapy in systemic sclerosis. Cells 14:1018. https:\/\/doi.org\/10.3390\/cells14131018","journal-title":"Cells"},{"key":"1574_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2672.2012.05344.x","volume":"113","author":"E Barrett","year":"2012","unstructured":"Barrett E, Ross R, O\u2019Toole PW, Fitzgerald GF, Stanton C (2012) \u03b3-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113:411\u2013417. https:\/\/doi.org\/10.1111\/j.1365-2672.2012.05344.x","journal-title":"J Appl Microbiol"},{"key":"1574_CR17","doi-asserted-by":"publisher","first-page":"e87876","DOI":"10.1371\/journal.pone.0087876","volume":"9","author":"K Berer","year":"2014","unstructured":"Berer K, Boziki M, Krishnamoorthy G (2014) Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease. PLoS ONE 9:e87876. https:\/\/doi.org\/10.1371\/journal.pone.0087876","journal-title":"PLoS ONE"},{"key":"1574_CR18","doi-asserted-by":"publisher","first-page":"S352","DOI":"10.14309\/00000434-201110002-00942","volume":"106","author":"T Borody","year":"2011","unstructured":"Borody T, Leis S, Campbell J, Torres M, Nowak A (2011) Fecal microbiota transplantation (FMT) in multiple sclerosis (MS): 942. Am J Gastroenterol 106:S352. https:\/\/doi.org\/10.14309\/00000434-201110002-00942","journal-title":"Am J Gastroenterol"},{"key":"1574_CR19","doi-asserted-by":"publisher","first-page":"16050","DOI":"10.1073\/pnas.1102999108","volume":"108","author":"JA Bravo","year":"2011","unstructured":"Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF (2011) Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 108:16050\u201316055. https:\/\/doi.org\/10.1073\/pnas.1102999108","journal-title":"Proc Natl Acad Sci USA"},{"key":"1574_CR20","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/1352458516682105","volume":"23","author":"A Budhram","year":"2017","unstructured":"Budhram A, Parvathy S, Kremenchutzky M, Silverman M (2017) Breaking down the gut microbiome composition in multiple sclerosis. Mult Scler 23:628\u2013636. https:\/\/doi.org\/10.1177\/1352458516682105","journal-title":"Mult Scler"},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/JIM.0000000000000192","volume":"63","author":"BL Cantarel","year":"2015","unstructured":"Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM (2015) Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med 63:729\u2013734. https:\/\/doi.org\/10.1097\/JIM.0000000000000192","journal-title":"J Investig Med"},{"key":"1574_CR22","unstructured":"Cekanaviciute E, Debelius J, Singh S, Runia T, Nelson C, Yoo B, Kanner R, Crabtree-Hartman E, Mazmanian S, Knight R (2016) Gut dysbiosis is a feature of MS and it is characterized by bacteria able to regulate lymphocyte differentiation in vitro. Proc 2016 ECTRIMS, London, UK, 14"},{"key":"1574_CR23","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL (2017) Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci USA 114:10713\u201310718. https:\/\/doi.org\/10.1073\/pnas.1711235114","journal-title":"Proc Natl Acad Sci USA"},{"key":"1574_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbr.2017.01.021","volume":"322","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, Zeng BH, Li WW, Zhou CJ, Fan SH, Cheng K, Zeng L, Zheng P, Fang L, Wei H (2017a) Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice. Behav Brain Res 322:34\u201341. https:\/\/doi.org\/10.1016\/j.bbr.2017.01.021","journal-title":"Behav Brain Res"},{"key":"1574_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbr.2017.01.021","volume":"322","author":"JJ Chen","year":"2017","unstructured":"Chen JJ, Zeng BH, Li WW, Zhou CJ, Fan SH, Cheng K, Zeng L, Zheng P, Fang L, Wei H, Xie P (2017b) Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice. Behav Brain Res 322:34\u201341. https:\/\/doi.org\/10.1016\/j.bbr.2017.01.021","journal-title":"Behav Brain Res"},{"key":"1574_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.625913","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhou J, Wang L (2021) Role and mechanism of gut microbiota in human disease. Front Cell Infect Microbiol 11:625913. https:\/\/doi.org\/10.3389\/fcimb.2021.625913","journal-title":"Front Cell Infect Microbiol"},{"key":"1574_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1323801","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, Li M, Tong C, Wang Y, He J, Shao Q, Liu Y, Wu Y, Song Y (2024) Regulation of miRNA expression in the prefrontal cortex by fecal microbiota transplantation in anxiety-like mice. Front Psychiatry 15:1323801. https:\/\/doi.org\/10.3389\/fpsyt.2024.1323801","journal-title":"Front Psychiatry"},{"key":"1574_CR28","doi-asserted-by":"publisher","first-page":"8168717","DOI":"10.1155\/2018\/8168717","volume":"2018","author":"F Chu","year":"2018","unstructured":"Chu F, Shi M, Lang Y, Shen D, Jin T, Zhu J, Cui L (2018) Gut microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives. Mediators Inflamm 2018:8168717. https:\/\/doi.org\/10.1155\/2018\/8168717","journal-title":"Mediators Inflamm"},{"key":"1574_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1700492","volume":"3","author":"I Cosorich","year":"2017","unstructured":"Cosorich I, Dalla-Costa G, Sorini C, Ferrarese R, Messina MJ, Dolpady J, Radice E, Mariani A, Testoni PA, Canducci F (2017) High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv 3:e1700492. https:\/\/doi.org\/10.1126\/sciadv.1700492","journal-title":"Sci Adv"},{"key":"1574_CR30","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","volume":"110","author":"EE Creemers","year":"2012","unstructured":"Creemers EE, Tijsen AJ, Pinto YM (2012) Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110:483\u2013495. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.247452","journal-title":"Circ Res"},{"key":"1574_CR31","doi-asserted-by":"publisher","first-page":"16099","DOI":"10.1074\/jbc.M115.642173","volume":"290","author":"X Dai","year":"2015","unstructured":"Dai X, Chen X, Chen Q, Shi L, Liang H, Zhou Z, Liu Q, Pang W, Hou D, Wang C (2015) MicroRNA-193a-3p reduces intestinal inflammation in response to microbiota via down-regulation of colonic PepT1. J Biol Chem 290:16099\u201316115. https:\/\/doi.org\/10.1074\/jbc.M115.642173","journal-title":"J Biol Chem"},{"key":"1574_CR32","doi-asserted-by":"publisher","first-page":"e19293","DOI":"10.1371\/journal.pone.0019293","volume":"6","author":"G Dalmasso","year":"2011","unstructured":"Dalmasso G, Nguyen HTT, Yan Y, Laroui H, Charania MA, Ayyadurai S, Sitaraman SV, Merlin D (2011) Microbiota modulate host gene expression via microRNAs. PLoS ONE 6:e19293. https:\/\/doi.org\/10.1371\/journal.pone.0019293","journal-title":"PLoS ONE"},{"key":"1574_CR33","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1038\/s41598-017-10403-0","volume":"7","author":"P Dalvi","year":"2017","unstructured":"Dalvi P, Sun B, Tang N, Pulliam L (2017) Immune activated monocyte exosomes alter microRNAs in brain endothelial cells and initiate an inflammatory response through the TLR4\/MyD88 pathway. Sci Rep 7:9954. https:\/\/doi.org\/10.1038\/s41598-017-10403-0","journal-title":"Sci Rep"},{"key":"1574_CR34","doi-asserted-by":"publisher","first-page":"106870","DOI":"10.1016\/j.phrs.2023.106870","volume":"194","author":"N Datta","year":"2023","unstructured":"Datta N, Johnson C, Kao D, Gurnani P, Alexander C, Polytarchou C, Monaghan TM (2023) MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis. Pharmacol Res 194:106870. https:\/\/doi.org\/10.1016\/j.phrs.2023.106870","journal-title":"Pharmacol Res"},{"key":"1574_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15:545\u2013558. https:\/\/doi.org\/10.1038\/nri3871","journal-title":"Nat Rev Immunol"},{"key":"1574_CR36","doi-asserted-by":"publisher","first-page":"725044","DOI":"10.3389\/fmolb.2021.725044","volume":"8","author":"GR Disner","year":"2021","unstructured":"Disner GR, Lopes-Ferreira M, Lima C (2021) Where the aryl hydrocarbon receptor meets the microRNAs: literature review of the last 10 years. Front Mol Biosci 8:725044. https:\/\/doi.org\/10.3389\/fmolb.2021.725044","journal-title":"Front Mol Biosci"},{"key":"1574_CR37","doi-asserted-by":"publisher","unstructured":"Doms S, Baines JF, Hendriks J (2025) Gut Microbiome Structure and Progression in Multiple Sclerosis: A Meta-Analysis Across 14 COHORTS. medRxiv, 2025.09.08.25335213. https:\/\/doi.org\/10.1101\/2025.09.08.25335213","DOI":"10.1101\/2025.09.08.25335213"},{"key":"1574_CR38","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.23860","volume":"73","author":"R Dutta","year":"2013","unstructured":"Dutta R, Chomyk AM, Chang A, Ribaudo MV, Deckard SA, Doud MK, Edberg DD, Bai B, Li M, Baranzini SE (2013) Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors. Ann Neurol 73:637\u2013645. https:\/\/doi.org\/10.1002\/ana.23860","journal-title":"Ann Neurol"},{"key":"1574_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/brainsci15030253","volume":"15","author":"A D\u017eidi\u0107 Krivi\u0107","year":"2025","unstructured":"D\u017eidi\u0107 Krivi\u0107 A, Begagi\u0107 E, Had\u017ei\u0107 S, Be\u0107irovi\u0107 A, Be\u0107irovi\u0107 E, Hibi\u0107 H, Tandir Lihi\u0107 L, Kadi\u0107 Vukas S, Be\u010duli\u0107 H, Kasapovi\u0107 T, Pojski\u0107 M (2025) Unveiling the Important Role of Gut Microbiota and Diet in Multiple Sclerosis. Brain Sci 15:253. https:\/\/doi.org\/10.3390\/brainsci15030253","journal-title":"Brain Sci"},{"key":"1574_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00281-025-01046-9","volume":"47","author":"M Edwards","year":"2025","unstructured":"Edwards M, Brockmann L (2025) Microbiota-dependent modulation of intestinal anti-inflammatory CD4\u2009+\u2009T cell responses. Semin Immunopathol 47:23. https:\/\/doi.org\/10.1007\/s00281-025-01046-9","journal-title":"Semin Immunopathol"},{"key":"1574_CR41","doi-asserted-by":"publisher","first-page":"e23555","DOI":"10.1002\/jbt.23555","volume":"38","author":"R Elsayed","year":"2024","unstructured":"Elsayed R, Fayez S, Rashed LA, Farghali M, Abdelhamid M, Alkaffas M (2024) Relation between microRNA-155 and inflammatory mediators in multiple sclerosis. J Biochem Mol Toxicol 38:e23555. https:\/\/doi.org\/10.1002\/jbt.23555","journal-title":"J Biochem Mol Toxicol"},{"key":"1574_CR42","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3389\/fneur.2020.00978","volume":"11","author":"PA Engen","year":"2020","unstructured":"Engen PA, Zaferiou A, Rasmussen H, Naqib A, Green SJ, Fogg LF, Forsyth CB, Raeisi S, Hamaker B, Keshavarzian A (2020) Single-arm, non-randomized, time series, single-subject study of fecal microbiota transplantation in multiple sclerosis. Front Neurol 11:978. https:\/\/doi.org\/10.3389\/fneur.2020.00978","journal-title":"Front Neurol"},{"key":"1574_CR43","doi-asserted-by":"publisher","first-page":"105762","DOI":"10.1016\/j.msard.2024.105762","volume":"89","author":"RS Farber","year":"2024","unstructured":"Farber RS, Walker EL, Diallo F, Onomichi K, Riley C, Zhang L, Zhu W, De Jager PL, Xia Z (2024) A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement. Mult Scler Relat Disord 89:105762. https:\/\/doi.org\/10.1016\/j.msard.2024.105762","journal-title":"Mult Scler Relat Disord"},{"key":"1574_CR44","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1038\/cti.2013.11","volume":"2","author":"V Farrokhi","year":"2013","unstructured":"Farrokhi V, Nemati R, Nichols FC, Yao X, Anstadt E, Fujiwara M, Grady J, Wakefield D, Castro W, Donaldson J (2013) Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis. Clin Transl Immunol 2:e8. https:\/\/doi.org\/10.1038\/cti.2013.11","journal-title":"Clin Transl Immunol"},{"key":"1574_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ncpgasthep0259","volume":"2","author":"A Fasano","year":"2005","unstructured":"Fasano A, Shea-Donohue T (2005) Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2:416\u2013422. https:\/\/doi.org\/10.1038\/ncpgasthep0259","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"1574_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2009.06.027","volume":"286","author":"F Fazekas","year":"2009","unstructured":"Fazekas F, Enzinger C, Wallner-Blazek M, Ropele S, Pluta-Fuerst A, Fuchs S (2009) Gender differences in MRI studies on multiple sclerosis. J Neurol Sci 286:28\u201330. https:\/\/doi.org\/10.1016\/j.jns.2009.06.027","journal-title":"J Neurol Sci"},{"key":"1574_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2186671","volume":"15","author":"EE Fekete","year":"2023","unstructured":"Fekete EE, Figeys D, Zhang X (2023) Microbiota-directed biotherapeutics: considerations for quality and functional assessment. Gut Microbes 15:2186671. https:\/\/doi.org\/10.1080\/19490976.2023.2186671","journal-title":"Gut Microbes"},{"key":"1574_CR48","doi-asserted-by":"publisher","unstructured":"Flanagan K, Gassner K, Lang M, Ozelyte J, Hausmann B, Crepaz D, Pjevac P, Gasche C, Berry D, Vesely C (2025) Human-derived microRNA 21 regulates indole and L-tryptophan biosynthesis transcripts in the gut commensal Bacteroides thetaiotaomicron. mBio e03928\u2013e03924. https:\/\/doi.org\/10.1128\/mbio.03928-24","DOI":"10.1128\/mbio.03928-24"},{"key":"1574_CR49","doi-asserted-by":"publisher","first-page":"1277102","DOI":"10.3389\/fimmu.2023.1277102","volume":"14","author":"Y Fu","year":"2023","unstructured":"Fu Y, Lyu J, Wang S (2023) The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective. Front Immunol 14:1277102. https:\/\/doi.org\/10.3389\/fimmu.2023.1277102","journal-title":"Front Immunol"},{"key":"1574_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","volume":"20","author":"TC Fung","year":"2017","unstructured":"Fung TC, Olson CA, Hsiao EY (2017) Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20:145\u2013155. https:\/\/doi.org\/10.1038\/nn.4476","journal-title":"Nat Neurosci"},{"key":"1574_CR51","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/nu15092211","volume":"15","author":"W Fusco","year":"2023","unstructured":"Fusco W, Lorenzo MB, Cintoni M, Porcari S, Rinninella E, Kaitsas F, Lener E, Mele MC, Gasbarrini A, Collado MC, Cammarota G, Ianiro G (2023) Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients 15:2211. https:\/\/doi.org\/10.3390\/nu15092211","journal-title":"Nutrients"},{"key":"1574_CR52","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s10753-020-01362-w","volume":"44","author":"S Gharehkhani Digehsara","year":"2021","unstructured":"Gharehkhani Digehsara S, Name N, Esfandiari B, Karim E, Taheri S, Tajabadi-Ebrahimi M, Arasteh J (2021) Effects of Lactobacillus casei Strain T2 (IBRC-M10783) on the Modulation of Th17\/Treg and Evaluation of miR-155, miR-25, and IDO-1 Expression in a Cuprizone-Induced C57BL\/6 Mouse Model of Demyelination. Inflammation 44:334\u2013343. https:\/\/doi.org\/10.1007\/s10753-020-01362-w","journal-title":"Inflammation"},{"key":"1574_CR53","doi-asserted-by":"publisher","first-page":"e40897","DOI":"10.1016\/j.heliyon.2024.e40897","volume":"10","author":"M Ghiasian","year":"2024","unstructured":"Ghiasian M, Bawand R, Jabarzadeh S, Moradi A (2024) Predictive factors and treatment challenges in malignant progression of relapsing-remitting multiple sclerosis. Heliyon 10:e40897. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40897","journal-title":"Heliyon"},{"key":"1574_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246157","volume":"16","author":"DS Goodin","year":"2021","unstructured":"Goodin DS, Khankhanian P, Gourraud PA, Vince N (2021) The nature of genetic and environmental susceptibility to multiple sclerosis. PLoS One 16:e0246157. https:\/\/doi.org\/10.1371\/journal.pone.0246157","journal-title":"PLoS One"},{"key":"1574_CR55","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/ni.3584","volume":"17","author":"Y Goto","year":"2016","unstructured":"Goto Y, Uematsu S, Kiyono H (2016) Epithelial glycosylation in gut homeostasis and inflammation. Nat Immunol 17:1244\u20131251. https:\/\/doi.org\/10.1038\/ni.3584","journal-title":"Nat Immunol"},{"key":"1574_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/femsre\/fuv038","volume":"40","author":"C Grandcl\u00e9ment","year":"2016","unstructured":"Grandcl\u00e9ment C, Tanni\u00e8res M, Mor\u00e9ra S, Dessaux Y, Faure D (2016) Quorum quenching: role in nature and applied developments. FEMS Microbiol Rev 40:86\u2013116. https:\/\/doi.org\/10.1093\/femsre\/fuv038","journal-title":"FEMS Microbiol Rev"},{"key":"1574_CR57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/jama.2017.7893","volume":"318","author":"A Gupta","year":"2017","unstructured":"Gupta A, Khanna S (2017) Fecal microbiota transplantation. JAMA 318:102\u2013102. https:\/\/doi.org\/10.1001\/jama.2017.7893","journal-title":"JAMA"},{"key":"1574_CR58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4110\/in.2011.11.1.11","volume":"11","author":"TY Ha","year":"2011","unstructured":"Ha TY (2011) The role of microRNAs in regulatory T cells and in the immune response. Immune Netw 11:11\u201341. https:\/\/doi.org\/10.4110\/in.2011.11.1.11","journal-title":"Immune Netw"},{"key":"1574_CR59","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.immuni.2015.09.007","volume":"43","author":"A Haghikia","year":"2015","unstructured":"Haghikia A, J\u00f6rg S, Duscha A, Berg J, Manzel A, Waschbisch A, Hammer A, Lee DH, May C, Wilck N (2015) Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43:817\u2013829. https:\/\/doi.org\/10.1016\/j.immuni.2015.09.007","journal-title":"Immunity"},{"key":"1574_CR60","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S (2014) Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1574_CR61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s40168-017-0321-3","volume":"5","author":"AE Hoban","year":"2017","unstructured":"Hoban AE, Stilling RM, Moloney M, Moloney G, Shanahan RD, Dinan F, Cryan TG, Clarke JF G (2017) Microbial regulation of microRNA expression in the amygdala and prefrontal cortex. Microbiome 5:102. https:\/\/doi.org\/10.1186\/s40168-017-0321-3","journal-title":"Microbiome"},{"key":"1574_CR62","doi-asserted-by":"publisher","first-page":"577356","DOI":"10.1016\/j.jneuroim.2020.577356","volume":"347","author":"SH Ibrahim","year":"2020","unstructured":"Ibrahim SH, El-Mehdawy KM, Seleem M, El-Sawalhi MM, Shaheen AA (2020) Serum ROCK2, miR-300 and miR-450b-5p levels in two different clinical phenotypes of multiple sclerosis: Relation to patient disability and disease progression. J Neuroimmunol 347:577356. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577356","journal-title":"J Neuroimmunol"},{"key":"1574_CR63","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.intimp.2012.01.008","volume":"12","author":"GV Idova","year":"2012","unstructured":"Idova GV, Alperina EL, Cheido MA (2012) Contribution of brain dopamine, serotonin and opioid receptors in the mechanisms of neuroimmunomodulation: evidence from pharmacological analysis. Int Immunopharmacol 12:618\u2013625. https:\/\/doi.org\/10.1016\/j.intimp.2012.01.008","journal-title":"Int Immunopharmacol"},{"key":"1574_CR64","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu S, Glanz BL (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7:12015. https:\/\/doi.org\/10.1038\/ncomms12015","journal-title":"Nat Commun"},{"key":"1574_CR65","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1039\/d0fo03210d","volume":"12","author":"J Jiang","year":"2021","unstructured":"Jiang J, Chu C, Wu C, Wang C, Zhang C, Li T, Zhai Q, Yu L, Tian F, Chen W (2021) Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials. Food Funct 12:2354\u20132377. https:\/\/doi.org\/10.1039\/d0fo03210d","journal-title":"Food Funct"},{"key":"1574_CR66","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ecco-jcc\/jjy038","volume":"12","author":"DG Johnston","year":"2018","unstructured":"Johnston DG, Williams MA, Thaiss CA, Cabrera-Rubio R, Raverdeau M, McEntee C, Cotter PD, Elinav E, O\u2019Neill LA, Corr SC (2018) Loss of microRNA-21 influences the gut microbiota, causing reduced susceptibility in a murine model of colitis. J Crohns Colitis 12:835\u2013848. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy038","journal-title":"J Crohns Colitis"},{"key":"1574_CR67","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/brain\/awp300","volume":"132","author":"A Junker","year":"2009","unstructured":"Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F, Bittner R, Lassmann H, Wekerle H, Hohlfeld R, Meinl E (2009) MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132:3342\u20133352. https:\/\/doi.org\/10.1093\/brain\/awp300","journal-title":"Brain"},{"key":"1574_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04846-w","author":"M Kalmaz","year":"2025","unstructured":"Kalmaz M, Mungan S, Demird\u00f6\u011fen BC (2025) Decoding the Potential Impact of Plasma hsa-miR-24-3p and hsa-miR-181d-3p Expression, Plasma IFN-\u03b3 Levels, and IFNG rs2069727 T\/C Genetic Variant on Multiple Sclerosis Risk and Glatiramer Acetate Treatment. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-04846-w","journal-title":"Mol Neurobiol"},{"key":"1574_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113442","volume":"423","author":"MJ Kamali","year":"2023","unstructured":"Kamali MJ, Salehi M, Fatemi S, Moradi F, Khoshghiafeh A, Ahmadifard M (2023) Locked nucleic acid (LNA): a modern approach to cancer diagnosis and treatment. Exp Cell Res 423:113442. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113442","journal-title":"Exp Cell Res"},{"key":"1574_CR70","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.4049\/jimmunol.1101211","volume":"188","author":"SW Kang","year":"2012","unstructured":"Kang SW, Kim SH, Lee N, Lee WW, Hwang KA, Shin MS, Lee SH, Kim WU, Kang I (2012) 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. J Immunol 188:5276\u20135282. https:\/\/doi.org\/10.4049\/jimmunol.1101211","journal-title":"J Immunol"},{"key":"1574_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439176","volume":"15","author":"M Karimi","year":"2024","unstructured":"Karimi M, Shirsalimi N, Hashempour Z, Salehi Omran H, Sedighi E, Beigi F, Mortezazadeh M (2024) Safety and efficacy of fecal microbiota transplantation (FMT) as a modern adjuvant therapy in various diseases and disorders: a comprehensive literature review. Front Immunol 15:1439176. https:\/\/doi.org\/10.3389\/fimmu.2024.1439176","journal-title":"Front Immunol"},{"key":"1574_CR71","doi-asserted-by":"publisher","first-page":"472","DOI":"10.30476\/ijms.2024.102246.3533","volume":"50","author":"N Karimi","year":"2025","unstructured":"Karimi N, Motovali Bashi M, Ghaderi-Zefrehei M, Lesch BJ (2025) hsa-miR-520d-3p and hsa-miR-449a are Candidate MicroRNA Regulators in Multiple Sclerosis. Iran J Med Sci 50:472\u2013480. https:\/\/doi.org\/10.30476\/ijms.2024.102246.3533","journal-title":"Iran J Med Sci"},{"key":"1574_CR73","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.omtm.2023.03.007","volume":"29","author":"V Kasina","year":"2023","unstructured":"Kasina V, Wahane A, Liu CH, Yang L, Nieh MP, Slack FJ, Bahal R (2023) Next-generation poly-L-histidine formulations for miRNA mimic delivery. Mol Ther Methods Clin Dev 29:271\u2013283. https:\/\/doi.org\/10.1016\/j.omtm.2023.03.007","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1574_CR74","doi-asserted-by":"publisher","first-page":"e7440","DOI":"10.1371\/journal.pone.0007440","volume":"4","author":"A Keller","year":"2009","unstructured":"Keller A, Leidinger P, Lange J, Borries A, Schroers H, Scheffler M, Lenhof HP, Ruprecht K, Meese E (2009) Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS ONE 4:e7440. https:\/\/doi.org\/10.1371\/journal.pone.0007440","journal-title":"PLoS ONE"},{"key":"1574_CR75","doi-asserted-by":"publisher","first-page":"498","DOI":"10.33631\/sabd.1563617","volume":"15","author":"D Koruyucu","year":"2025","unstructured":"Koruyucu D, Demird\u00f6\u011fen BC (2025) Exploring miRNA Inhibiting Therapeutic Strategies for Multiple Sclerosis: Insights from Experimental Autoimmune Encephalomyelitis Studies \u2013 A Traditional Review. Sa\u011fl\u0131k Bilimlerinde De\u011fer 15:498\u2013508. https:\/\/doi.org\/10.33631\/sabd.1563617","journal-title":"Sa\u011fl\u0131k Bilimlerinde De\u011fer"},{"key":"1574_CR76","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrneurol.2012.203","volume":"8","author":"M Krumbholz","year":"2012","unstructured":"Krumbholz M, Derfuss T, Hohlfeld R, Meinl E (2012) B cells and antibodies in multiple sclerosis pathogenesis and therapy. Nat Rev Neurol 8:613\u2013623. https:\/\/doi.org\/10.1038\/nrneurol.2012.203","journal-title":"Nat Rev Neurol"},{"key":"1574_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087247","volume":"24","author":"G La Rosa","year":"2023","unstructured":"La Rosa G, Lonardo MS, Cacciapuoti N, Muscariello E, Guida B, Faraonio R, Santillo M, Damiano S (2023) Dietary polyphenols, microbiome, and multiple sclerosis: from molecular anti-inflammatory and neuroprotective mechanisms to clinical evidence. Int J Mol Sci 24:7247. https:\/\/doi.org\/10.3390\/ijms24087247","journal-title":"Int J Mol Sci"},{"key":"1574_CR78","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.3390\/microorganisms11112840","volume":"11","author":"T Laeeq","year":"2023","unstructured":"Laeeq T, Vongsavath T, Tun KM, Hong AS (2023) The potential role of fecal microbiota transplant in the reversal or stabilization of multiple sclerosis symptoms: a Literature Review on Efficacy and Safety. Microorganisms 11:2840. https:\/\/doi.org\/10.3390\/microorganisms11112840","journal-title":"Microorganisms"},{"key":"1574_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03116","volume":"9","author":"H Lassmann","year":"2019","unstructured":"Lassmann H (2019) Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol 9:3116. https:\/\/doi.org\/10.3389\/fimmu.2018.03116","journal-title":"Front Immunol"},{"key":"1574_CR80","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s1471-4914(00)01909-2","volume":"7","author":"H Lassmann","year":"2001","unstructured":"Lassmann H, Br\u00fcck W, Lucchinetti C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 7:115\u2013121. https:\/\/doi.org\/10.1016\/s1471-4914(00)01909-2","journal-title":"Trends Mol Med"},{"key":"1574_CR81","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.copbio.2012.08.005","volume":"24","author":"JG Leblanc","year":"2013","unstructured":"Leblanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M (2013) Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 24:160\u2013168. https:\/\/doi.org\/10.1016\/j.copbio.2012.08.005","journal-title":"Curr Opin Biotechnol"},{"key":"1574_CR82","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3390\/ijms20061487","volume":"20","author":"HJ Lee","year":"2019","unstructured":"Lee HJ (2019) Microbe-Host Communication by Small RNAs in Extracellular Vesicles: Vehicles for Transkingdom RNA Transportation. Int J Mol Sci 20:1487. https:\/\/doi.org\/10.3390\/ijms20061487","journal-title":"Int J Mol Sci"},{"key":"1574_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250236","volume":"53","author":"PC Lehman","year":"2023","unstructured":"Lehman PC, Ghimire S, Price JD, Ramer-Tait AE, Mangalam AK (2023) Diet-microbiome-immune interplay in multiple sclerosis: understanding the impact of phytoestrogen metabolizing gut bacteria. Eur J Immunol 53:2250236. https:\/\/doi.org\/10.1002\/eji.202250236","journal-title":"Eur J Immunol"},{"key":"1574_CR84","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrd4359","volume":"13","author":"Z Li","year":"2014","unstructured":"Li Z, Rana TM (2014) Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 13:622\u2013638. https:\/\/doi.org\/10.1038\/nrd4359","journal-title":"Nat Rev Drug Discov"},{"key":"1574_CR85","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12602-024-10402-w","volume":"17","author":"W Li","year":"2025","unstructured":"Li W, Zeng Y, Zhong J, Hu Y, Xiong X, Zhou Y, Fu L (2025) Probiotics Exert Gut Immunomodulatory Effects by Regulating the Expression of Host miRNAs. Probiotics Antimicrob Proteins 17:557\u2013568. https:\/\/doi.org\/10.1007\/s12602-024-10402-w","journal-title":"Probiotics Antimicrob Proteins"},{"key":"1574_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08288-z","author":"D Liao","year":"2025","unstructured":"Liao D, Zhang Y, Li S, Tang H, Bai X (2025) miRNAs in neurodegenerative diseases: from target screening to precision therapy. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-025-08288-z","journal-title":"Neurol Sci"},{"key":"1574_CR87","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","volume":"15","author":"JF Lima","year":"2018","unstructured":"Lima JF, Cerqueira L, Figueiredo C, Oliveira C, Azevedo NF (2018) Anti-miRNA oligonucleotides: A comprehensive guide for design. RNA Biol 15:338\u2013352. https:\/\/doi.org\/10.1080\/15476286.2018.1445959","journal-title":"RNA Biol"},{"key":"1574_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2025.1545690","volume":"19","author":"K Lin","year":"2025","unstructured":"Lin K, Lin W, Guo Z, Chen C, Chen L, Cai X (2025) Plasma exosomal miRNA expression and gut microbiota dysbiosis are associated with cognitive impairment in Alzheimer\u2019s disease. Front Neurosci 19:1545690. https:\/\/doi.org\/10.3389\/fnins.2025.1545690","journal-title":"Front Neurosci"},{"key":"1574_CR89","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.chom.2015.12.005","volume":"19","author":"S Liu","year":"2016","unstructured":"Liu S, da Cunha AP, Rezende RM, Cialic R, Wei Z, Bry L, Comstock LE, Gandhi R, Weiner HL (2016) The host shapes the gut microbiota via fecal microRNA. Cell Host Microbe 19:32\u201343. https:\/\/doi.org\/10.1016\/j.chom.2015.12.005","journal-title":"Cell Host Microbe"},{"key":"1574_CR90","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.chom.2019.10.008","volume":"26","author":"S Liu","year":"2019","unstructured":"Liu S, Rezende RM, Moreira TG, Tankou SK, Cox LM, Wu M, Song A, Dhang FH, Wei Z, Costamagna G, Weiner HL (2019) Oral administration of miR-30d from feces of MS patients suppresses MS-like symptoms in mice by expanding Akkermansia muciniphila. Cell Host Microbe 26:779\u2013794.e8. https:\/\/doi.org\/10.1016\/j.chom.2019.10.008","journal-title":"Cell Host Microbe"},{"key":"1574_CR91","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/157015911795596711","volume":"9","author":"I Loma","year":"2011","unstructured":"Loma I, Heyman R (2011) Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol 9:409\u2013416. https:\/\/doi.org\/10.2174\/157015911795596711","journal-title":"Curr Neuropharmacol"},{"key":"1574_CR92","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1182\/blood-2016-05-718668","volume":"128","author":"Y Lu","year":"2016","unstructured":"Lu Y, Hippen KL, Lemire AL, Gu J, Wang W, Ni X, Ranganathan P, Levine BL, Riley JL, June CH (2016) miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency. Blood 128:1424\u20131435. https:\/\/doi.org\/10.1182\/blood-2016-05-718668","journal-title":"Blood"},{"key":"1574_CR93","doi-asserted-by":"publisher","first-page":"102456","DOI":"10.1016\/j.omtn.2025.102456","volume":"36","author":"NA Luzan","year":"2025","unstructured":"Luzan NA, Zamay TN, Zhang P, Narodov AA, Zamay GS, Kichkailo AS, Berezovski MV, Kolovskaya OS (2025) Innovative aptamer approaches in glial tumor diagnostics and therapy: Progress and future directions. Mol Ther Nucleic Acids 36:102456. https:\/\/doi.org\/10.1016\/j.omtn.2025.102456","journal-title":"Mol Ther Nucleic Acids"},{"key":"1574_CR94","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1600-065X.2011.01080.x","volume":"245","author":"L Macia","year":"2012","unstructured":"Macia L, Thorburn AN, Binge LC, Marino E, Rogers KE, Maslowski KM, Vieira AT, Kranich J, Mackay CR (2012) Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev 245:164\u2013176. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01080.x","journal-title":"Immunol Rev"},{"key":"1574_CR95","doi-asserted-by":"publisher","first-page":"e459","DOI":"10.1212\/NXI.0000000000000459","volume":"5","author":"S Makkawi","year":"2018","unstructured":"Makkawi S, Camara-Lemarroy C, Metz L (2018) Fecal microbiota transplantation associated with 10 years of stability in a patient with SPMS. Neurol Neuroimmunol Neuroinflamm 5:e459. https:\/\/doi.org\/10.1212\/NXI.0000000000000459","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1574_CR96","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1177\/1352458517731400","volume":"24","author":"TS Malinova","year":"2018","unstructured":"Malinova TS, Dijkstra CD, de Vries HE (2018) Serotonin: A mediator of the gut\u2013brain axis in multiple sclerosis. Mult Scler 24:1144\u20131150. https:\/\/doi.org\/10.1177\/1352458517731400","journal-title":"Mult Scler"},{"key":"1574_CR97","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1096\/fj.201701479R","volume":"32","author":"I Manna","year":"2018","unstructured":"Manna I, Iaccino E, Dattilo V, Barone S, Vecchio E, Mimmi S, Filippelli E, Demonte G, Polidoro S, Granata A (2018) Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients. FASEB J 32:4241\u20134246. https:\/\/doi.org\/10.1096\/fj.201701479R","journal-title":"FASEB J"},{"key":"1574_CR98","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","volume":"12","author":"P Markowiak-Kope\u0107","year":"2020","unstructured":"Markowiak-Kope\u0107 P, \u015ali\u017cewska K (2020) The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients 12:1107. https:\/\/doi.org\/10.3390\/nu12041107","journal-title":"Nutrients"},{"key":"1574_CR99","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1172\/JCI76304","volume":"125","author":"EA Mayer","year":"2015","unstructured":"Mayer EA, Tillisch K, Gupta A (2015) Gut\/brain axis and the microbiota. J Clin Invest 125:926\u2013938. https:\/\/doi.org\/10.1172\/JCI76304","journal-title":"J Clin Invest"},{"key":"1574_CR100","doi-asserted-by":"publisher","unstructured":"McCoy CE (2017) miR-155 dysregulation and therapeutic intervention in multiple sclerosis. Regul Inflamm Signal Health Dis 111\u2013131. https:\/\/doi.org\/10.1007\/978-3-319-60104-5_6","DOI":"10.1007\/978-3-319-60104-5_6"},{"key":"1574_CR101","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1053\/j.gastro.2010.07.040","volume":"139","author":"LB McKenna","year":"2010","unstructured":"McKenna LB, Schug J, Vourekas A, McKenna JB, Bramswig NC, Friedman JR, Kaestner KH (2010) MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 139:1654\u20131664e1. https:\/\/doi.org\/10.1053\/j.gastro.2010.07.040","journal-title":"Gastroenterology"},{"key":"1574_CR102","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2016.01.008","volume":"292","author":"M Melnikov","year":"2016","unstructured":"Melnikov M, Belousova O, Murugin V, Pashenkov \u041c, Boyko A (2016) The role of dopamine in modulation of Th-17 immune response in multiple sclerosis. J Neuroimmunol 292:97\u2013101. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.01.008","journal-title":"J Neuroimmunol"},{"key":"1574_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911502","volume":"23","author":"A Menon","year":"2022","unstructured":"Menon A, Abd-Aziz N, Khalid K, Poh CL, Naidu R (2022) MiRNA: a promising therapeutic target in cancer. Int J Mol Sci 23:11502. https:\/\/doi.org\/10.3390\/ijms231911502","journal-title":"Int J Mol Sci"},{"key":"1574_CR104","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1089\/ars.2012.5068","volume":"19","author":"D Miljkovi\u0107","year":"2013","unstructured":"Miljkovi\u0107 D, Spasojevi\u0107 I (2013) Multiple sclerosis: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 19:2286\u20132334. https:\/\/doi.org\/10.1089\/ars.2012.5068","journal-title":"Antioxid Redox Signal"},{"key":"1574_CR105","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1128\/aem.62.5.1589-1592.1996","volume":"62","author":"TL Miller","year":"1996","unstructured":"Miller TL, Wolin MJ (1996) Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol 62:1589\u20131592. https:\/\/doi.org\/10.1128\/aem.62.5.1589-1592.1996","journal-title":"Appl Environ Microbiol"},{"key":"1574_CR106","doi-asserted-by":"publisher","first-page":"e0137429","DOI":"10.1371\/journal.pone.0137429","volume":"10","author":"S Miyake","year":"2015","unstructured":"Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS ONE 10:e0137429. https:\/\/doi.org\/10.1371\/journal.pone.0137429","journal-title":"PLoS ONE"},{"key":"1574_CR107","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bbr.2017.07.026","volume":"334","author":"GM Moloney","year":"2017","unstructured":"Moloney GM, O\u2019Leary OF, Salvo-Romero E, Desbonnet L, Shanahan F, Dinan TG, Clarke G, Cryan JF (2017) Microbial regulation of hippocampal miRNA expression: Implications for transcription of kynurenine pathway enzymes. Behav Brain Res 334:50\u201354. https:\/\/doi.org\/10.1016\/j.bbr.2017.07.026","journal-title":"Behav Brain Res"},{"key":"1574_CR108","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.coph.2019.08.005","volume":"48","author":"GM Moloney","year":"2019","unstructured":"Moloney GM, Dinan TG, Clarke G, Cryan JF (2019) Microbial regulation of microRNA expression in the brain\u2013gut axis. Curr Opin Pharmacol 48:120\u2013126. https:\/\/doi.org\/10.1016\/j.coph.2019.08.005","journal-title":"Curr Opin Pharmacol"},{"key":"1574_CR109","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","volume":"7","author":"DJ Morrison","year":"2016","unstructured":"Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7:189\u2013200. https:\/\/doi.org\/10.1080\/19490976.2015.1134082","journal-title":"Gut Microbes"},{"key":"1574_CR110","doi-asserted-by":"publisher","first-page":"e200069","DOI":"10.1212\/NXI.0000000000200069","volume":"10","author":"M Mu\u00f1oz-San Mart\u00edn","year":"2022","unstructured":"Mu\u00f1oz-San Mart\u00edn M, G\u00f3mez I, Quiroga-Varela A, Gonzalez-Del R\u00edo M, Robles Cede\u00f1o R, \u00c1lvarez G, Bux\u00f3 M, Miguela A, Villar LM, Castillo-Villalba J (2022) miRNA signature in CSF from patients with primary progressive multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 10:e200069. https:\/\/doi.org\/10.1212\/NXI.0000000000200069","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1574_CR111","doi-asserted-by":"publisher","first-page":"15426","DOI":"10.1074\/jbc.M117.788596","volume":"292","author":"K Nakata","year":"2017","unstructured":"Nakata K, Sugi Y, Narabayashi H, Kobayakawa T, Nakanishi Y, Tsuda M, Hosono A, Kaminogawa S, Hanazawa S, Takahashi K (2017) Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4. J Biol Chem 292:15426\u201315433. https:\/\/doi.org\/10.1074\/jbc.M117.788596","journal-title":"J Biol Chem"},{"key":"1574_CR112","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2982.2010.01620.x","volume":"23","author":"K Neufeld","year":"2011","unstructured":"Neufeld K, Kang N, Bienenstock J, Foster JA (2011) Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 23:255\u2013e119. https:\/\/doi.org\/10.1111\/j.1365-2982.2010.01620.x","journal-title":"Neurogastroenterol Motil"},{"key":"1574_CR113","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2023.03.219","volume":"165","author":"AJ Noble","year":"2023","unstructured":"Noble AJ, Nowak JK, Adams AT, Uhlig HH, Satsangi J (2023) Defining interactions between the genome, epigenome, and the environment in inflammatory bowel disease: progress and prospects. Gastroenterology 165:44\u201360e2. https:\/\/doi.org\/10.1053\/j.gastro.2023.03.219","journal-title":"Gastroenterology"},{"key":"1574_CR114","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1093\/brain\/awr200","volume":"134","author":"F Noorbakhsh","year":"2011","unstructured":"Noorbakhsh F, Ellestad KK, Maingat F, Warren KG, Han MH, Steinman L, Baker GB, Power C (2011) Impaired neurosteroid synthesis in multiple sclerosis. Brain 134:2703\u20132721. https:\/\/doi.org\/10.1093\/brain\/awr200","journal-title":"Brain"},{"key":"1574_CR115","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12602-017-9264-0","volume":"9","author":"AV Oleskin","year":"2017","unstructured":"Oleskin AV, Shenderov BA, Rogovsky VS (2017) Role of neurochemicals in the interaction between the microbiota and the immune and the nervous system of the host organism. Probiotics Antimicrob Proteins 9:215\u2013234. https:\/\/doi.org\/10.1007\/s12602-017-9264-0","journal-title":"Probiotics Antimicrob Proteins"},{"key":"1574_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.718220","volume":"12","author":"B Parodi","year":"2021","unstructured":"Parodi B, Kerlero de Rosbo N (2021) The gut-brain axis in multiple sclerosis. Is its dysfunction a pathological trigger or a consequence of the disease? Front Immunol 12:718220. https:\/\/doi.org\/10.3389\/fimmu.2021.718220","journal-title":"Front Immunol"},{"key":"1574_CR117","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2014.04.037","volume":"273","author":"A Paul","year":"2014","unstructured":"Paul A, Branton W, Walsh J, Polyak M, Lu JQ, Baker G, Power C (2014) GABA transport and neuroinflammation are coupled in multiple sclerosis: regulation of the GABA transporter-2 by ganaxolone. Neuroscience 273:24\u201338. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.04.037","journal-title":"Neuroscience"},{"key":"1574_CR118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003479","volume":"9","author":"DJ Perkins","year":"2013","unstructured":"Perkins DJ, Polumuri SK, Pennini ME, Lai W, Xie P, Vogel SN (2013) Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production. PLoS Pathog 9:e1003479. https:\/\/doi.org\/10.1371\/journal.ppat.1003479","journal-title":"PLoS Pathog"},{"key":"1574_CR119","doi-asserted-by":"publisher","first-page":"eaat4301","DOI":"10.1126\/scitranslmed.aat4301","volume":"10","author":"R Planas","year":"2018","unstructured":"Planas R, Santos R, Tomas-Ojer P, Cruciani C, Lutterotti A, Faigle W, Schaeren-Wiemers N, Espejo C, Eixarch H, Pinilla C (2018) GDP-l-fucose synthase is a CD4\u2009+\u2009T cell-specific autoantigen in DRB3*02:02 patients with multiple sclerosis. Sci Transl Med 10:eaat4301. https:\/\/doi.org\/10.1126\/scitranslmed.aat4301","journal-title":"Sci Transl Med"},{"key":"1574_CR120","doi-asserted-by":"publisher","unstructured":"Qiao S, Zhao Y, Li K, Sun Y, Sun L, Hou X, Tian H, Ye K, Nie Y, Tian W (2019) Lentivirus-mediated long-term overexpression of specific microRNA for complementary miRNA pairs in mammalian cells. bioRxiv 717330. https:\/\/doi.org\/10.1101\/717330","DOI":"10.1101\/717330"},{"key":"1574_CR121","first-page":"587800","volume":"18","author":"F Rafie Sedaghat","year":"2026","unstructured":"Rafie Sedaghat F, Ahmadi S, Samadpour Zahmat-Dar T, Saedi S, Samadi Kafil H (2026) The Effect of the Mediterranean Diet on Gut Microbiota and Its Impact on Neurodegenerative Diseases: A Narrative Review. Nutr Diet Suppl 18:587800 [Note: verify DOI\/publication year]","journal-title":"Nutr Diet Suppl"},{"key":"1574_CR122","doi-asserted-by":"publisher","first-page":"1700144","DOI":"10.1002\/mnfr.201700144","volume":"61","author":"A Rodr\u00edguez-Nogales","year":"2017","unstructured":"Rodr\u00edguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Garcia F, Olivares M, Rodr\u00edguez-Cabezas ME, G\u00e1lvez J (2017) Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Mol Nutr Food Res 61:1700144. https:\/\/doi.org\/10.1002\/mnfr.201700144","journal-title":"Mol Nutr Food Res"},{"key":"1574_CR123","doi-asserted-by":"publisher","first-page":"eaau8826","DOI":"10.1126\/scitranslmed.aau8826","volume":"10","author":"JJ Sabatino Jr","year":"2018","unstructured":"Sabatino JJ Jr, Zamvil SS (2018) T cells take aim at a ubiquitous autoantigen in multiple sclerosis. Sci Transl Med 10:eaau8826. https:\/\/doi.org\/10.1126\/scitranslmed.aau8826","journal-title":"Sci Transl Med"},{"key":"1574_CR124","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3389\/fimmu.2017.01391","volume":"8","author":"M Saresella","year":"2017","unstructured":"Saresella M, Mendozzi L, Rossi V, Mazzali F, Piancone F, Larosa F, Marventano I, Caputo D, Felis GE, Clerici M (2017) Immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: a pilot study. Front Immunol 8:1391. https:\/\/doi.org\/10.3389\/fimmu.2017.01391","journal-title":"Front Immunol"},{"key":"1574_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01390","volume":"11","author":"M Saresella","year":"2020","unstructured":"Saresella M, Marventano I, Barone M, La Rosa F, Piancone F, Mendozzi L, D\u2019Arma A, Rossi V, Pugnetti L, Roda G (2020) Alterations in circulating fatty acid are associated with gut microbiota dysbiosis and inflammation in multiple sclerosis. Front Immunol 11:1390. https:\/\/doi.org\/10.3389\/fimmu.2020.01390","journal-title":"Front Immunol"},{"key":"1574_CR126","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1177\/0963689719873890","volume":"28","author":"G Schepici","year":"2019","unstructured":"Schepici G, Silvestro S, Bramanti P, Mazzon E (2019) The gut microbiota in multiple sclerosis: an overview of clinical trials. Cell Transpl 28:1507\u20131527. https:\/\/doi.org\/10.1177\/0963689719873890","journal-title":"Cell Transpl"},{"key":"1574_CR127","doi-asserted-by":"publisher","first-page":"101952","DOI":"10.1016\/j.xcrm.2025.101952","volume":"6","author":"LA Schwerdtfeger","year":"2025","unstructured":"Schwerdtfeger LA, Montini F, Lanser TB, Ekwudo MN, Zurawski J, Tauhid S, Glanz BI, Chu R, Bakshi R, Chitnis T (2025) Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med 6:101952. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101952","journal-title":"Cell Rep Med"},{"key":"1574_CR128","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43042-023-00475-9","volume":"25","author":"NMH Shaheen","year":"2024","unstructured":"Shaheen NMH, Sherif MMSSE, El Sayed AH, El Toukhy MM, Ahmed SRMS, Samy LA, Tamim HH (2024) The significance of miRNA-191-5P and miRNA-24-3P as novel biomarkers for multiple sclerosis: a case\u2013control study. Egypt J Med Hum Genet 25:2. https:\/\/doi.org\/10.1186\/s43042-023-00475-9","journal-title":"Egypt J Med Hum Genet"},{"key":"1574_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.578648","volume":"11","author":"SK Shahi","year":"2020","unstructured":"Shahi SK, Jensen SN, Murra AC, Tang N, Guo H, Gibson-Corley KN, Zhang J, Karandikar NJ, Murray JA, Mangalam AK (2020) Human commensal Prevotella histicola ameliorates disease as effectively as interferon-beta in the experimental autoimmune encephalomyelitis. Front Immunol 11:578648. https:\/\/doi.org\/10.3389\/fimmu.2020.578648","journal-title":"Front Immunol"},{"key":"1574_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138368","volume":"285","author":"B Shan","year":"2025","unstructured":"Shan B, Zhao C, Peng C, Miao Y, Lei S, Zhao L, Jia M, Pan S, Gong J, Wang Q (2025) Theabrownin from Pu-erh tea attenuated high-fat diet-induced metabolic syndrome in rat by regulating microRNA and affecting gut microbiota. Int J Biol Macromol 285:138368. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138368","journal-title":"Int J Biol Macromol"},{"key":"1574_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/nu15204466","volume":"15","author":"Y Shin","year":"2023","unstructured":"Shin Y, Han S, Kwon J, Ju S, Choi TG, Kang I, Kim SS (2023) Roles of short-chain fatty acids in inflammatory bowel disease. Nutrients 15:4466. https:\/\/doi.org\/10.3390\/nu15204466","journal-title":"Nutrients"},{"key":"1574_CR132","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.1007\/s11033-011-1437-5","volume":"39","author":"SR Siegel","year":"2012","unstructured":"Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L (2012) Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 39:6219\u20136225. https:\/\/doi.org\/10.1007\/s11033-011-1437-5","journal-title":"Mol Biol Rep"},{"key":"1574_CR134","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1177\/1352458513490542","volume":"19","author":"HB S\u00f8ndergaard","year":"2013","unstructured":"S\u00f8ndergaard HB, Hesse D, Krakauer M, S\u00f8rensen PS, Sellebjerg F (2013) Differential microRNA expression in blood in multiple sclerosis. Mult Scler 19:1849\u20131857. https:\/\/doi.org\/10.1177\/1352458513490542","journal-title":"Mult Scler"},{"key":"1574_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.552101","volume":"11","author":"HB S\u00f8ndergaard","year":"2021","unstructured":"S\u00f8ndergaard HB, Airas L, Christensen JR, Nielsen BR, B\u00f6rnsen L, Oturai A, Sellebjerg F (2021) Pregnancy-induced changes in microRNA expression in multiple sclerosis. Front Immunol 11:552101. https:\/\/doi.org\/10.3389\/fimmu.2020.552101","journal-title":"Front Immunol"},{"key":"1574_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262412167","volume":"26","author":"B Stanimirov","year":"2025","unstructured":"Stanimirov B, \u0110ani\u0107 M, Pavlovi\u0107 N, Zaklan D, Lazarevi\u0107 S, Mikov M, Stankov K (2025) Gut\u2013brain axis and bile acid signaling: linking microbial metabolism to brain function and metabolic regulation. Int J Mol Sci 26:12167. https:\/\/doi.org\/10.3390\/ijms262412167","journal-title":"Int J Mol Sci"},{"key":"1574_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115500","volume":"257","author":"J Sun","year":"2023","unstructured":"Sun J, Xu M, Ru J, James-Bott A, Xiong D, Wang X, Cribbs AP (2023) Small molecule-mediated targeting of microRNAs for drug discovery: experiments, computational techniques, and disease implications. Eur J Med Chem 257:115500. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115500","journal-title":"Eur J Med Chem"},{"key":"1574_CR137","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cen3.12638","volume":"12","author":"D Takewaki","year":"2021","unstructured":"Takewaki D, Yamamura T (2021) Gut microbiome dysbiosis shapes disease course in the different stages of multiple sclerosis. Clin Exp Neuroimmunol 12:87\u201388. https:\/\/doi.org\/10.1111\/cen3.12638","journal-title":"Clin Exp Neuroimmunol"},{"key":"1574_CR138","doi-asserted-by":"publisher","first-page":"fcae078","DOI":"10.1093\/braincomms\/fcae078","volume":"6","author":"IL Tan","year":"2024","unstructured":"Tan IL, Modderman R, Stachurska A, Almeida R, de Vries R, Heersema DJ, Gacesa R, Wijmenga C, Jonkers IH, Meilof JF, Withoff S (2024) Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencing. Brain Commun 6:fcae078. https:\/\/doi.org\/10.1093\/braincomms\/fcae078","journal-title":"Brain Commun"},{"key":"1574_CR139","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chom.2018.10.001","volume":"24","author":"Y Teng","year":"2018","unstructured":"Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A, Hutchins E, Mu J, Deng Z, Luo C (2018a) Plant-derived exosomal microRNAs shape the gut microbiota. Cell Host Microbe 24:637\u2013652e8. https:\/\/doi.org\/10.1016\/j.chom.2018.10.001","journal-title":"Cell Host Microbe"},{"key":"1574_CR140","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chom.2018.10.001","volume":"24","author":"Y Teng","year":"2018","unstructured":"Teng Y, Ren Y, Sayed M, Hu X, Lei C, Kumar A, Hutchins E, Mu J, Deng Z, Luo C, Sundaram K, Sriwastva MK, Zhang L, Hsieh M, Reiman R, Haribabu B, Yan J, Jala VR, Miller DM, Van Keuren-Jensen K, Merchant ML, McClain CJ, Park JW, Egilmez NK, Zhang HG (2018b) Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota. Cell Host Microbe 24:637\u2013652e8. https:\/\/doi.org\/10.1016\/j.chom.2018.10.001","journal-title":"Cell Host Microbe"},{"key":"1574_CR141","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/acn3.51368","volume":"8","author":"A Tripathi","year":"2021","unstructured":"Tripathi A, Pandit I, Perles A, Zhou Y, Cheng F, Dutta R (2021) Identifying miRNAs in multiple sclerosis gray matter lesions that correlate with atrophy measures. Ann Clin Transl Neurol 8:1279\u20131291. https:\/\/doi.org\/10.1002\/acn3.51368","journal-title":"Ann Clin Transl Neurol"},{"key":"1574_CR142","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s00415-023-12127-w","volume":"271","author":"CC Tsai","year":"2024","unstructured":"Tsai CC, Jette S, Tremlett H (2024) Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review. J Neurol 271:1108\u20131123. https:\/\/doi.org\/10.1007\/s00415-023-12127-w","journal-title":"J Neurol"},{"key":"1574_CR143","unstructured":"Utleg AG (2024) The Relationships Among Diet, Bacterial Taxa, Fecal Short Chain Fatty Acids (SCFA) and Symptoms Among Healthy Women and Women With Irritable Bowel Syndrome. University of Washington. [Note: thesis \u2013 no DOI]"},{"key":"1574_CR144","doi-asserted-by":"publisher","DOI":"10.2196\/16162","volume":"9","author":"J van Pamelen","year":"2020","unstructured":"van Pamelen J, van Olst L, Budding AE, de Vries HE, Visser LH, Group BS (2020) Alterations of gut microbiota and the brain-immune-intestine axis in patients with relapsing-remitting multiple sclerosis after treatment with oral cladribine: protocol for a prospective observational study. JMIR Res Protoc 9:e16162. https:\/\/doi.org\/10.2196\/16162","journal-title":"JMIR Res Protoc"},{"key":"1574_CR145","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fcimb.2020.00098","volume":"10","author":"KEW Vendrik","year":"2020","unstructured":"Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ, Ducarmon QR, Keller JJ, Kuijper EJ, Contarino MF (2020) Fecal Microbiota Transplantation in Neurological Disorders. Front Cell Infect Microbiol 10:98. https:\/\/doi.org\/10.3389\/fcimb.2020.00098","journal-title":"Front Cell Infect Microbiol"},{"key":"1574_CR146","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1128\/JCM.01360-10","volume":"48","author":"R Verma","year":"2010","unstructured":"Verma R, Verma AK, Ahuja V, Paul J (2010) Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India. J Clin Microbiol 48:4279\u20134282. https:\/\/doi.org\/10.1128\/JCM.01360-10","journal-title":"J Clin Microbiol"},{"key":"1574_CR147","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nic.2016.12.001","volume":"27","author":"A Vidal-Jordana","year":"2017","unstructured":"Vidal-Jordana A, Montalban X (2017) Multiple sclerosis: epidemiologic, clinical, and therapeutic aspects. Neuroimaging Clin 27:195\u2013204. https:\/\/doi.org\/10.1016\/j.nic.2016.12.001","journal-title":"Neuroimaging Clin"},{"key":"1574_CR148","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","volume":"118","author":"JW Wang","year":"2019","unstructured":"Wang JW, Kuo CH, Kuo FC, Wang YK, Hsu WH, Yu FJ, Hu HM, Hsu PI, Wang JY, Wu DC (2019) Fecal microbiota transplantation: Review and update. J Formos Med Assoc 118:S23\u2013S31. https:\/\/doi.org\/10.1016\/j.jfma.2018.08.011","journal-title":"J Formos Med Assoc"},{"key":"1574_CR149","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21640","volume":"65","author":"HL Weiner","year":"2009","unstructured":"Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65:239\u2013248. https:\/\/doi.org\/10.1002\/ana.21640","journal-title":"Ann Neurol"},{"key":"1574_CR150","doi-asserted-by":"publisher","first-page":"277765","DOI":"10.3389\/fmicb.2017.01896","volume":"8","author":"MR Williams","year":"2017","unstructured":"Williams MR, Stedtfeld RD, Tiedje JM, Hashsham SA (2017) MicroRNAs-based inter-domain communication between the host and members of the gut microbiome. Front Microbiol 8:277765. https:\/\/doi.org\/10.3389\/fmicb.2017.01896","journal-title":"Front Microbiol"},{"key":"1574_CR151","doi-asserted-by":"publisher","first-page":"759323","DOI":"10.3389\/fimmu.2021.759323","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Li Q, Liu J, Liu Y, Xu Y, Zhang R, Yu Y, Wang Y, Yang C (2021) Integrating Serum Metabolome and Gut Microbiome to Evaluate the Benefits of Lauric Acid on Lipopolysaccharide-Challenged Broilers. Front Immunol 12:759323. https:\/\/doi.org\/10.3389\/fimmu.2021.759323","journal-title":"Front Immunol"},{"key":"1574_CR152","doi-asserted-by":"publisher","first-page":"e38807","DOI":"10.1016\/j.heliyon.2024.e38807","volume":"10","author":"D Xu","year":"2024","unstructured":"Xu D, Ren L, Zhang W, Wu S, Yu M, He X, Wei Z (2024) Therapeutic effects and mechanisms of fecal microbiota transplantation on EAE partly through HPA axis-mediated neuroendocrine regulation. Heliyon 10:e38807. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38807","journal-title":"Heliyon"},{"key":"1574_CR153","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s10620-021-07262-x","volume":"67","author":"X Yang","year":"2022","unstructured":"Yang X, Wan J, Li N, He C, Zhang Y, Ren Y, Li X, Zhu Y, Liu F, Xia L, Lu N (2022) MiR155 Disrupts the Intestinal Barrier by Inducing Intestinal Inflammation and Altering the Intestinal Microecology in Severe Acute Pancreatitis. Dig Dis Sci 67:2209\u20132219. https:\/\/doi.org\/10.1007\/s10620-021-07262-x","journal-title":"Dig Dis Sci"},{"key":"1574_CR154","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264\u2013276. https:\/\/doi.org\/10.1016\/j.cell.2015.02.047","journal-title":"Cell"},{"key":"1574_CR155","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1016\/j.neuroimage.2011.10.053","volume":"59","author":"HJ Yu","year":"2012","unstructured":"Yu HJ, Christodoulou C, Bhise V, Greenblatt D, Patel Y, Serafin D, Maletic-Savatic M, Krupp LB, Wagshul ME (2012) Multiple white matter tract abnormalities underlie cognitive impairment in RRMS. NeuroImage 59:3713\u20133722. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.10.053","journal-title":"NeuroImage"},{"key":"1574_CR156","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00205-17","author":"C Yuan","year":"2018","unstructured":"Yuan C, Burns MB, Subramanian S, Blekhman R (2018) Interaction between host microRNAs and the gut microbiota in colorectal cancer. mSystems. https:\/\/doi.org\/10.1128\/mSystems.00205-17","journal-title":"mSystems"},{"key":"1574_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1441733","volume":"15","author":"A Zabalza","year":"2024","unstructured":"Zabalza A, Pappolla A, Comabella M, Montalban X, Malhotra S (2024) MiRNA-based therapeutic potential in multiple sclerosis. Front Immunol 15:1441733. https:\/\/doi.org\/10.3389\/fimmu.2024.1441733","journal-title":"Front Immunol"},{"key":"1574_CR158","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2013.09.019","volume":"266","author":"J Zhang","year":"2014","unstructured":"Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L (2014) MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266:56\u201363. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.09.019","journal-title":"J Neuroimmunol"},{"key":"1574_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2022.111437","volume":"157","author":"M Zhao","year":"2022","unstructured":"Zhao M, Zhang J, Liu T, Wang J, Cai H, Zhang X, Quay Huai Xia D, Feng F, Tang J (2022) Differential modulations of lauric acid and its glycerides on high fat diet-induced metabolic disorders and gut microbiota dysbiosis. Food Res Int 157:111437. https:\/\/doi.org\/10.1016\/j.foodres.2022.111437","journal-title":"Food Res Int"},{"key":"1574_CR160","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/art.39485","volume":"68","author":"S Zhou","year":"2016","unstructured":"Zhou S, Wang Y, Meng Y, Xiao C, Liu Z, Brohawn P, Higgs BW, Jallal B, Jia Q, Qu B (2016) In vivo therapeutic success of microRNA-155 antagomir in a mouse model of lupus alveolar hemorrhage. Arthritis Rheumatol 68:953\u2013964. https:\/\/doi.org\/10.1002\/art.39485","journal-title":"Arthritis Rheumatol"}],"updated-by":[{"DOI":"10.1007\/s12223-026-01596-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01574-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01574-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01574-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:41:06Z","timestamp":1790826066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-026-01574-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":160,"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1007\/s12223-026-01574-3","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"1 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Images of Figures 1 and 2 were switched.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12223-026-01596-x","URL":"https:\/\/doi.org\/10.1007\/s12223-026-01596-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Tabriz University of Medical Sciences (IR.TBZMED.REC.1403.745).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"<b>Consent for publication<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}